Send Enquiry

EVERMED
Injection
Packaging and packing Type
| 1
MRP :
₹296
PTR :
₹225.52
PTS :
₹202.97
Hospital use Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Injectable PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
From Vibcare Pharma's Evermed division comes Zonalam S 1.5, an injection containing Cefoperazone 1000 mg and Sulbactam 500 mg. It is a cephalosporin antibiotic combined with a beta-lactamase inhibitor and is packed as 1.5gm.
Cefoperazone and sulbactam act together in this injection. Cefoperazone kills the infecting bacteria by blocking the formation of their cell wall. Sulbactam protects it by inhibiting beta-lactamase enzymes produced by some bacteria, which would otherwise break down cefoperazone and stop it from working.
Zonalam S 1.5 is indicated for bacterial infections such as lower respiratory tract infections, intra-abdominal infections, gynaecological infections, skin and soft tissue infections, urinary tract infections, septicaemia and bone and joint infections.
Given only by a doctor or nurse.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Zonalam S 1.5 Injection is part of Vibcare Pharma's injectable range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Injectable PCD franchisePCD pharma franchise with Vibcare
Also part of our Antibiotic PCD franchise range.
Zonalam S 1.5 is an injection of Cefoperazone 1000 mg with Sulbactam 500 mg used against a range of bacterial infections. Main uses: lower respiratory tract infections caused by susceptible bacteria; intra-abdominal infections, including peritonitis and biliary tract infections; gynaecological infections; skin and soft tissue infections; urinary tract infections.
Common side effects of Zonalam S 1.5 Injection include pain, redness or swelling at the injection site; loose motions or diarrhoea; skin rash or itching; nausea or vomiting; fever and chills; rise in liver enzyme levels in blood tests. Get medical help at once if you notice serious allergic reactions, including anaphylaxis; severe skin reactions such as Stevens-Johnson syndrome; liver inflammation or cholestatic jaundice.
Zonalam S 1.5 Injection contains Cefoperazone 1000 mg + Sulbactam 500 mg. Zonalam S 1.5 Injection is given by a doctor or nurse, who decides the dose and how often it is given.
The MRP of Zonalam S 1.5 Injection is ₹296 for a pack of 1. For chemists and distributors, the PTR is ₹225.52 and the PTS is ₹202.97.
Zonalam S 1.5 Injection contains Cefoperazone 1000 mg + Sulbactam 500 mg. It comes in a pack of 1.
Cefoperazone and sulbactam act together in this injection. Cefoperazone kills the infecting bacteria by blocking the formation of their cell wall. Sulbactam protects it by inhibiting beta-lactamase enzymes produced by some bacteria, which would otherwise break down cefoperazone and stop it from working.
Must not be used by anyone with a history of serious hypersensitivity (such as anaphylaxis or Stevens-Johnson syndrome) to cephalosporins, penicillins or other beta-lactam antibiotics. Must not be used by anyone with a previous allergic reaction to sulbactam. Check with a doctor first if you have bleeding problems, low vitamin K levels or take blood thinners. Check with a doctor first if you have liver or kidney disease, or a past history of colitis. Check with a doctor first if you are pregnant or breastfeeding.
Zonalam S 1.5 Injection is a brand of Vibcare Pharma, sold through its Evermed division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner